Matthew Maxwell Donley, EVP, Operations & Strategy at Aurinia Pharmaceuticals Inc. (AUPH), sold 81,330 shares at $5.51 ($448K) on 2024-03-06, disclosed to the SEC on 2024-03-07.
Open-market sale of $448k AUPH by EVP, Operations & Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.51 | 40,665 | $224K | 50.0% |
| 2 | $5.51 | 40,665 | $224K | 50.0% |
| Total | $5.51 avg | 81,330 | $448K | 100% |
| Filing → |
| AUPH | SELL | 2022-03-04 | $37K | — | Filing → |
| AUPH | BUY | 2021-05-12 | $100K | — | Filing → |